Jack Nathan Medical Corp.
JNHMF · OTC
1/31/2025 | 1/31/2024 | 1/31/2023 | 1/31/2022 | |
|---|---|---|---|---|
| Revenue | $8,706 | $19,145 | $15,488 | $9,639 |
| % Growth | -54.5% | 23.6% | 60.7% | – |
| Cost of Goods Sold | $1,335 | $4,668 | $3,668 | $2,714 |
| Gross Profit | $7,371 | $14,477 | $11,819 | $6,925 |
| % Margin | 84.7% | 75.6% | 76.3% | 71.8% |
| R&D Expenses | $0 | $0 | $237 | $546 |
| G&A Expenses | $9,207 | $6,194 | $15,556 | $12,376 |
| SG&A Expenses | $9,484 | $7,219 | $16,572 | $12,807 |
| Sales & Mktg Exp. | $265 | $466 | $261 | $431 |
| Other Operating Expenses | $366 | $13,702 | $316 | $1,080 |
| Operating Expenses | $9,851 | $20,921 | $17,125 | $14,432 |
| Operating Income | -$2,480 | -$2,305 | -$6,961 | -$8,469 |
| % Margin | -28.5% | -12% | -44.9% | -87.9% |
| Other Income/Exp. Net | -$34 | $166 | -$28 | $235 |
| Pre-Tax Income | -$2,514 | -$2,139 | -$6,989 | -$8,233 |
| Tax Expense | $16 | $806 | -$86 | -$218 |
| Net Income | $7,465 | -$6,636 | -$7,077 | -$7,808 |
| % Margin | 85.7% | -34.7% | -45.7% | -81% |
| EPS | -0.029 | -0.078 | -0.084 | -0.095 |
| % Growth | 62.5% | 7.6% | 11.5% | – |
| EPS Diluted | -0.03 | -0.078 | -0.084 | -0.095 |
| Weighted Avg Shares Out | 248,825 | 85,534 | 84,298 | 82,230 |
| Weighted Avg Shares Out Dil | 87,434 | 85,533 | 84,298 | 82,230 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $12 | $35 |
| Interest Expense | $22 | $0 | $410 | $182 |
| Depreciation & Amortization | $851 | $891 | $786 | $445 |
| EBITDA | -$1,539 | -$4,310 | -$4,412 | -$6,104 |
| % Margin | -17.7% | -22.5% | -28.5% | -63.3% |